Skip to main content

Advertisement

Log in

Lack of association of tumor necrosis factor-alpha gene polymorphisms with disease susceptibility and severity in Behçet’s disease

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Although it has been reported that the MHC class I molecule, HLA-B51, is a risk factor for Behçet’s disease (BD), contribution of the tumor necrosis factor (TNF) genes, which are located in the vicinity of the HLA-B locus, to the genetic susceptibility for BD has yet to be elucidated. The purpose of this study was to analyze the effect of TNF-α promoter polymorphisms at positions −308, −238 and −376 on the susceptibility, severity and clinical features of BD. The TNF-α gene sequences from 107 patients with BD and 102 healthy subjects were amplified by the polymerase chain reaction. Sequence analysis of the TNF-α gene locus, which contains promoter polymorphisms at positions −376, −308, and −238, was performed with a DNA sequencing kit on automated sequencer. The patients were classified according to disease severity and clinical features. Serum TNF-α level in the study groups was measured by sandwich enzyme immunoassay. In patients with BD the frequencies of TNF-α −308 (19.4% vs 18.4%), −238 (3.7% vs 5.9%), and −376 (0.9% vs 2.9%) gene polymorphisms were not found to be significantly different from those in healthy subjects. The TNF-α gene polymorphisms did not show any association with disease severity or clinical features. Serum TNF-α level was significantly higher in patients with BD than in healthy controls (3.10±1.45 pg/ml vs 2.43±1.94 pg/ml, P < 0.01). Serum TNF-α level was not found to be significantly associated with disease severity, activity, clinical findings and TNF-α genotypes. The results of this study suggest that the TNF-α gene polymorphisms are unlikely to play an important role in the pathogenesis and severity of BD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lehner T (1999) Immunopathogenesis of Behçet’s disease. Ann Med Interne (Paris) 150:483–487

    CAS  Google Scholar 

  2. Gül A (2001) Behçet’s disease: an update on the pathogenesis. Clin Exp Rheumatol 19 [Suppl 24]:S6–S12

    Google Scholar 

  3. Direskeneli H (2001) Behçet’s disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis 60:996–1002

    Article  CAS  PubMed  Google Scholar 

  4. Mege JL, Dilsen N, Sanguedolce V, Gül A, Bongrand P, Roux H, Ocal L, Inanc M, Capo C (1993) Overproduction of monocyte derived tumor necrosis factor α, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet’s disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 20:1544–1549

    CAS  Google Scholar 

  5. Yamashita N, Kaneoka H, Kaneko S, Takeno M, Oneda K, Koizumi H, Kogure M, Inaba G, Sakane T (1997) Role of γδ T lymphocytes in the development of Behçet’s disease. Clin Exp Immunol 107:241–247

    Article  CAS  PubMed  Google Scholar 

  6. Kaneko S, Suzuki N, Yamashita N, Nagafuchi H, Nakajima T, Wakisaka S, Yamamoto S, Sakane T (1997) Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behçet’s disease (BD) in Japan. Clin Exp Immunol 108:204–212

    Article  CAS  PubMed  Google Scholar 

  7. Beutler B, Cerami A (1989) The biology of cachectin/TNF-α primary mediator of the host response. Annu Rev Immunol 7:625–655

    CAS  PubMed  Google Scholar 

  8. Golfeld AE, Doyle C, Maniatis T (1990) Human tumor necrosis factor α gene regulation by virus and lipopolysaccharide. Proc Natl Acad Sci U S A 87:9769–9773

    PubMed  Google Scholar 

  9. Han J, Brown T, Beutler B (1990) Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J Exp Med 171:465–475

    Article  CAS  PubMed  Google Scholar 

  10. Beutler B (1995) TNF, immunity and inflammatory disease: lessons of the past decade. J Invest Med 43:227–235

    CAS  Google Scholar 

  11. Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR (1999) Behçet’s disease, the silk road and HLA-B51: historical and geographical perspectives. Tissue Antigens 54:213–220

    Article  CAS  PubMed  Google Scholar 

  12. Mizuki N, Ohno S, Sato T, Ishihara M, Miyata S, Nakamura S, Naruse T, Mizuki H, Tsuji K, Inoko H (1995) Microsatellite polymorphism between the tumor necrosis factor and HLA-B genes in Behçet’s disease. Hum Immunol 43:129–135

    Article  CAS  PubMed  Google Scholar 

  13. Campbell RD, Trowsdale J (1993) Map of the human MHC. Immunol Today 14:349–352

    Article  CAS  PubMed  Google Scholar 

  14. Beutler B, Cerami A (1988) Tumor necrosis, cachexia, shock and inflammation: a common mediator. Ann Rev Biochem 57:505–518

    Article  CAS  PubMed  Google Scholar 

  15. Verjans GM, Messer G, Weiss EH, van der Linden SM, Kijlstra A (1992) Polymorphism of the tumor necrosis factor region in relation to disease: an overview. Rheum Dis Clin North Am 18:177–185

    CAS  PubMed  Google Scholar 

  16. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDewitt HO (1990) Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor α: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A 87:1233–1237

    CAS  PubMed  Google Scholar 

  17. Wilson AG, di Giovine FS, Blakemore AI, Duff GW (1992) Single base polymorphism in the human tumour necrosis factor α (TNF-α) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1:353–359

    CAS  Google Scholar 

  18. D’Alfonso S, Richiardi PM (1994) A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 39:150–154

    CAS  PubMed  Google Scholar 

  19. Pociot F, Briant L, Jongeneel CV, Molvig J, Worsaae H, Abbal M, Thomsen M, Nerup J, Cambon-Thomsen A (1993) Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 23:224–231

    CAS  PubMed  Google Scholar 

  20. Hamann A, Mantzoros C, Vidal-Puig A, Flier JS (1995) Genetic variability in the TNF-α promoter is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Commun 211:833–839

    Article  CAS  PubMed  Google Scholar 

  21. Rood MJ, van Krugten MV, Zanelli E, van der Linden MW, Keijsers V, Schreuder GMT, Verduyn W, Westendorp RG, de Vries RR, Breedveld FC, Verweij CL, Huizinga TW (2000) TNF−308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 43:129–134

    Article  CAS  PubMed  Google Scholar 

  22. Brinkman BMN, Huizinga TWJ, Kurban SS, van der Velde EA, Schreuder GMT, Hazes JMW, Breedveld FC, Verweij CL (1997) Tumour necrosis factor α gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheumatol 36:516–521

    Article  CAS  PubMed  Google Scholar 

  23. Höhler T, Schaper T, Schneider PM, Meyer zum Buschenfelde KH, Marker-Hermann E (1998) Association of different tumor necrosis factor α promoter alleles frequencies with ankylosing spondylitis in HLA-B27 positive individuals. Arthritis Rheum 41:1489–1492

    Article  PubMed  Google Scholar 

  24. Verity DH, Wallace GR, Vaughan RW, Kondeatis E, Madanat W, Zureikat H, Fayyad F, Marr JE, Kanawati CA, Stanford MR (1999) HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behçet’s disease. Tissue Antigens 54:264–272

    Article  CAS  PubMed  Google Scholar 

  25. Öz D, Karslı F, Atalay A, Şahin Ş (2000) TNF-alpha gene polymorphisms in Behçet’s disease. In: Bang D, Lee ES, Lee S (eds). Proceedings of the 9th international conference on Behçet’s disease 2000, May 27–29. Design Mecca Publishing, Seoul, pp161–165

    Google Scholar 

  26. Duymaz-Tozkir J, Gül A, Uyar FA, Özbek U, Saruhan-Direskeneli G (2003) Tumour necrosis factor-alpha gene promoter region −308 and –376 G→A polymorphisms in Behçet’s disease. Clin Exp Rheumatol 21:15–18

    Google Scholar 

  27. Ahmad T, Wallace GR, James T, Neville M, Bunce M, Mulcahy-Hawes K, Armuzzi A, Crawshaw J, Fortune F, Walton R, Stanford MR, Welsh KI, Marshall SE, Jewell DP (2003) Mapping the HLA association in Behçet’s disease. A role for tumor necrosis factor polymorphisms? Arthritis Rheum 48:807–813

    CAS  Google Scholar 

  28. Lee EB, Kim JY, Lee YJ, Park MH, Song YW (2003) TNF and TNF receptor polymorphisms in Korean Behçet’s disease patients. Hum Immunol 64:614–620

    CAS  PubMed  Google Scholar 

  29. International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080

    PubMed  Google Scholar 

  30. Krause I, Rosen Y, Kaplan I, Milo G, Guedj D, Molad Y, Weinberger A (1999) Recurrent aphthous stomatitis in Behçet’s disease: clinical features and correlation with systemic disease expression and severity. J Oral Pathol Med 28:193–196

    CAS  PubMed  Google Scholar 

  31. Miller SA, Dykes DD, Polesky HT (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 16:1215

    CAS  PubMed  Google Scholar 

  32. Gül A, İnanç M, Öcal L, Aral O, Koniçe M (2000) Familial aggregation of Behçet’s disease in Turkey. Ann Rheum Dis 59:622–625

    Article  PubMed  Google Scholar 

  33. Mizuki N, Ohno S, Tanaka H, Sugimura K, Seki T, Mizuki N, Kera J, Inaba G, Tsuji K, Inoko H (1992) Association of HLA-B51 and lack of association of class II alleles with Behçet’s disease. Tissue Antigens 40:22–30

    CAS  PubMed  Google Scholar 

  34. Hamzaoui K, Hamza M, Ayed K (1990) Production of TNF-alpha and IL-1 in active Behçet’s disease. J Rheumatol 17:1428–1429

    CAS  PubMed  Google Scholar 

  35. Yamakawa Y, Sugita Y, Takahashi Y, Yamakawa T, Tanaka S, Nakamura S, Fukushima J, Kawamoto S, Ohno S, Okuda K, et al (1993) Gene expression of tumour necrosis factor-α (TNF-α) and heat-shock protein (HSP) 70 in patients with Behçet’s disease. Arch Dermatol Res 285:505–508

    Article  CAS  PubMed  Google Scholar 

  36. Goossens PH, Verburg RJ, Breedveld FC (2001) Remission of Behçet’s syndrome with tumour necrosis factor α blocking therapy. Ann Rheum Dis 60:637

    Article  CAS  PubMed  Google Scholar 

  37. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumour necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci U S A 94:3195–3199

    Article  CAS  PubMed  Google Scholar 

  38. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N, Roland S, Mahieu P, Malaise M, De Groote D, Louis R, Belaiche J (1998) Tumour necrosis factor (TNF) gene polymorphism influences TNF-α production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 113:401–406

    Article  CAS  PubMed  Google Scholar 

  39. Brinkman BMN, Zuijdgeest D, Kaijzel EL, Breedveld FC, Verweij CL (1996) Relevance of the tumor necrosis factor alpha (TNFα) −308 promoter polymorphism in TNF-α gene regulation. J Inflamm 46:32–41

    CAS  Google Scholar 

  40. Uglialoro AM, Turbay D, Pesavento PA, Delgado JC, McKenzie FE, Gribben JG, Hartl D, Yunis EJ, Goldfeld AE (1998) Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-α gene promoter. Tissue Antigens 52:359–367

    CAS  PubMed  Google Scholar 

  41. Skoog T, Van’t Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J, Eriksson P, Hamsten A (1999) A common functional polymorphism (C→A substitution at position -863) in the promoter region of the tumour necrosis factor-α (TNF-α) gene associated with reduced circulating levels of TNF-α. Hum Mol Genet 8:1443–1449

    Article  CAS  PubMed  Google Scholar 

  42. Allen RD (1999) Polymorphism of the human TNF-α promoter—random variation or functional diversity? Mol Immunol 36:1017–1027

    Article  CAS  PubMed  Google Scholar 

  43. Pociot F, D’Alfonso S, Compasso S, Scorza R, Richiardi PM (1995) Functional analysis of a new polymorphism in the human TNF alpha gene promoter. Scand J Immunol 42:501–504

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study is supported in part by Ankara University Research Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Aşkın Ateş.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ateş, A., Kinikli, G., Düzgün, N. et al. Lack of association of tumor necrosis factor-alpha gene polymorphisms with disease susceptibility and severity in Behçet’s disease. Rheumatol Int 26, 348–353 (2006). https://doi.org/10.1007/s00296-005-0610-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-005-0610-1

Keywords

Navigation